13.07.2015 Views

Flotte Terry CV - American Society of Gene & Cell Therapy

Flotte Terry CV - American Society of Gene & Cell Therapy

Flotte Terry CV - American Society of Gene & Cell Therapy

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Curriculum Vitae: Terence R. <strong>Flotte</strong>Cystic Fibrosis Foundation "Immuno-Modulatory Adeno-Associated <strong>Gene</strong> <strong>Therapy</strong> for Hyper IgE-Mediated Lung Inflammation in Cystic Fibrosis"April 2004 to March 2006 (INACTIVE)Cystic Fibrosis Foundation (Project PI: <strong>Flotte</strong>)"Anti-Inflammatory <strong>Gene</strong> <strong>Therapy</strong> in CF", Special RFA for Cystic Fibrosis Airway Infection andInflammation. $125,000/year, July 1, 2001 - June 30, 2005Alpha One Foundation/Fernandez Liver Disease Award, “Molecular Therapies for alpha 1-antitrypsin liverdisease”, $100,000/year (Project PI: <strong>Flotte</strong>)November 2000-2002Juvenile Diabetes Research Foundation (JDRF) “Cytokine-mediated gene therapy for type I diabetesmellitus” $98,500/yr (P.I. = Mark Atkinson; Co-PI = <strong>Flotte</strong>) April 1999- March 2001Alpha One Foundation Young Investigator Award, “Adeno-associated virus (AAV) vectors for skeletalmuscle mediated gene therapy for alpha 1-antitrypsin (AAT) deficiency: Preclinical study in non-humanprimates”, $25,000/year (Project PI: <strong>Flotte</strong>, Fellow: Sihong Song) July 1999 to June 2001National Institutes <strong>of</strong> Health (NIDDK) R01-DK51809 “Stategies to improve adeno-associated virus vectorpersistence and expression” $166,000/year Direct Costs (Project PI: <strong>Flotte</strong>)September 1996 to September 2000* The competitive renewal <strong>of</strong> this grant scored at the 3 rd percentile, but it was incorporated into the PPGDK58327 listed above.National Institutes <strong>of</strong> Health/National <strong>Gene</strong> Vector Laboratory, “Production and Distribution <strong>of</strong> arecombinant AAV reference standard stock” (Project PI: <strong>Flotte</strong>) $75,000October 1999Cystic Fibrosis Foundation Research Grant, “Adeno-associated Virus Vectors for <strong>Gene</strong> <strong>Therapy</strong> <strong>of</strong> CysticFibrosis” (Bridge Funding) $100,000/year (Project PI: <strong>Flotte</strong>)September 1998 to September 1999Howard Hughes Medical Institutions (HHMI) Pilot and Feasibility Project Grant “Strategies to improve thepersistence <strong>of</strong> adeno-associated virus (AAV) vectors” $25,000/year (Project PI: <strong>Flotte</strong>)July 1996 to June 1998.Cystic Fibrosis Foundation <strong>Gene</strong> <strong>Therapy</strong> Research Grant, "Episomal Persistence <strong>of</strong> DNA virus vectors"$50,000/year (Project PI: <strong>Flotte</strong>)December 1994 to December 1997.Cystic Fibrosis Foundation Leroy Matthews Physician Scientist AwardVariable to $85,000/year (Project PI: <strong>Flotte</strong>)July 1991 to June 1995Co-investigator on CF Research Development Project (CF Foundation)$50,000/year (Project PI: <strong>Flotte</strong>; PPG Director: William Guggino, Ph.D.)February 1992 to June 1996Page 4 <strong>of</strong> 29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!